116 research outputs found

    Therapeutic theophylline concentrations increase intracellular cAMP in humans in vivo

    Get PDF

    Biodiversity modelling in practice - predicting bird and woody plant species richness on farmlands

    Get PDF
    In light of decreasing species richness on farmland and an increasing awareness of biodiversity issues among customers and food companies, concepts and models to evaluate and enhance farmland biodiversity are greatly needed. It is important that the models are easy to apply as they have to be utilized by practitioners such as farmers and their consultants. In this study, simple but valid predictors were identified to rapidly assess the species richness of birds and woody plants in hedgerows, an important farmland landscape element. Hedgerows were sampled in seven agricultural landscapes throughout Germany. By means of automatic model selection procedures, linear regression models were estimated to predict bird and woody plant species richness. Cross validation procedures were carried out in order to visualize model selection uncertainty and estimate the prediction error. Due to a rather high prediction error, the model for plants can only be recommended for use when field work is not feasible. The model for birds, however, explained 70.8% of the variance in species numbers. It may help farmers, food companies and nature conservation agencies to rapidly evaluate bird species richness in hedgerows on farmland and to identify potentials and appropriate measures for enhancing it

    Mammographic density and risk of breast cancer by age and tumor characteristics

    Get PDF
    Introduction: Understanding whether mammographic density (MD) is associated with all breast tumor subtypes and whether the strength of association varies by age is important for utilizing MD in risk models. Methods: Data were pooled from six studies including 3414 women with breast cancer and 7199 without who underwent screening mammography. Percent MD was assessed from digitized film-screen mammograms using a computer-assisted threshold technique. We used polytomous logistic regression to calculate breast cancer odds according to tumor type, histopathological characteristics, and receptor (estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor (HER2)) status by age (51%) versus average density (11-25%). Women ages 2.1 cm) versus small tumors and positive versus negative lymph node status (P’s < 0.01). For women ages <55 years, there was a stronger association of MD with ER-negative breast cancer than ER-positive tumors compared to women ages 55–64 and ≥65 years (Page-interaction = 0.04). MD was positively associated with both HER2-negative and HER2-positive tumors within each age group. Conclusion: MD is strongly associated with all breast cancer subtypes, but particularly tumors of large size and positive lymph nodes across all ages, and ER-negative status among women ages <55 years, suggesting high MD may play an important role in tumor aggressiveness, especially in younger women

    Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo

    Get PDF
    Connective tissue growth factor (CCN2) is a major pro-fibrotic factor that frequently acts downstream of transforming growth factor beta (TGF-β)-mediated fibrogenic pathways. Much of our knowledge of CCN2 in fibrosis has come from studies in which its production or activity have been experimentally attenuated. These studies, performed both in vitro and in animal models, have demonstrated the utility of pharmacological inhibitors (e.g. tumor necrosis factor alpha (TNF-α), prostaglandins, peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists, statins, kinase inhibitors), neutralizing antibodies, antisense oligonucleotides, or small interfering RNA (siRNA) to probe the role of CCN2 in fibrogenic pathways. These investigations have allowed the mechanisms regulating CCN2 production to be more clearly defined, have shown that CCN2 is a rational anti-fibrotic target, and have established a framework for developing effective modalities of therapeutic intervention in vivo
    corecore